A stated preference survey to explore patient preferences for novel preventive migraine treatments.

ABSTRACT:

Objective

The objective of this study was to explore patient preference for attributes of calcitonin gene-related peptide (CGRP) inhibitors for the preventive treatment of migraine and to describe differences in treatment preferences between patients.

Background

CGRP inhibitors are a novel class of migraine drugs specifically developed for the preventive treatment of migraine. Clinicians should understand patient preferences for CGRP inhibitors to inform and support prescribing choices.

Methods

Patients with migraine in the US and Germany were recruited to participate in an online discrete choice experiment (DCE) survey, which presented hypothetical treatment choices using five attributes: mode of administration, side effects, migraine frequency, migraine severity, an

SUBMITTER: Hubig LT 

PROVIDER: S-EPMC9826196 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature